# Stereotaxis Completes Acquisition of Robocath to Expand Robotic Cardiology Platform

> ma · REPORTED · 2026-07-09

Stereotaxis announced on July 9, 2026 the completion of its previously announced acquisition of Robocath, a robotic catheter navigation company, strengthening its position as a leader in robotic-assisted cardiac electrophysiology procedures.

About Stereotaxis: Stereotaxis develops robotic systems and digital infrastructure for minimally invasive cardiac catheterization procedures, serving electrophysiology labs at hospitals worldwide.

- Company: Stereotaxis
- Sector: medical devices
- Primary source: https://www.dicardiology.com/

---
Source: MedFuel Intel news monitor. Verification tier: REPORTED. Informational only, not investment advice. Corrections: media@medfuelinc.com.